RIVANNA Study Shows Non-Physicians Can Operate Accuro XV for Musculoskeletal Imaging
RIVANNA Medical announced in a press release the results of a study showing that its Accuro XV automated musculoskeletal imaging system can produce diagnostic-quality images of extremity injuries when operated by non-physicians with minimal training.
The study, led by physicians from UVA Health and UT Southwestern Medical Center, involved 205 patients aged five or older with wrist or ankle injuries. After one hour of hands-on training, clinical research assistants and emergency physicians each performed scans using Accuro XV. Fifty scans from each group were reviewed blind, and both groups achieved similar image quality scores, averaging 3.6 and 3.7 out of 5. More than 90 percent of scans were rated adequate for diagnostic interpretation.
The research found no significant difference in patient comfort between Accuro XV scans and standard X-ray imaging. The system’s automated image acquisition guided users through a predefined scanning path, allowing consistent imaging results regardless of operator experience.
Accuro XV is a portable ultrasound platform designed for point-of-care musculoskeletal imaging. It uses a three-dimensional probe for automated volumetric image capture and includes AI-based modules such as BoneEnhance for anatomical segmentation and CADe/x for fracture detection. Both modules are advancing toward FDA clearance under RIVANNA’s clinical decision-support platform.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Sep 29 University Medical Center Göttingen Adopts MDClone Clinical Data Platform Sep 29 LUNGevity Awards $2 Million for Lung Nodule Risk Studies Sep 28 Deep Longevity to Launch Accrua Telehealth Platform in US Sep 28 United Imaging Intelligence Releases Medical Video AI Framework Sep 28 Orca Dental AI Brings CephX Imaging Tools to Planet DDS Cloud 9Life AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Industry analysis
2025 Global Business Services Agenda: Gen AI Takes Center Stage
This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.
Read moreYou may also like
CMS Creates Procedure Code for Computer Aided Neuraxial Guidance
Carestream Updates DRX LC Detector With AI Noise Reduction
ARPA-H Awards UpDoc Up to $9.2 Million for Clinical AI
VALOR Network Selects RADIN Health for Federal Teleradiology Services
Trust AI Integrates VELMENI Dental Imaging With Isaac PracticeOS
Daily AI Brief: the AI news that matters, in your inbox.